Cerulean Pharma appoints new board member
This article was originally published in Scrip
Executive Summary
Cerulean Pharma has named Stuart A Arbuckle to its board of directors, effective 26 June. Mr Arbuckle is currently executive vice president and chief commercial officer at Vertex Pharmaceuticals where he oversees Vertex's global commercial team. Prior to joining Vertex, Mr Arbuckle held multiple commercial leadership roles at Amgen, including vice-president and general manager, oncology business unit.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.